Center for Generative AI Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Daiichi Sankyo US ยท 1 day ago

Center for Generative AI Intern

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies. The Center for Generative AI is seeking a highly motivated intern to support the design and evaluation of generative AI solutions in the pharmaceutical industry.

Health CareTherapeuticsWellness
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Support the development and testing of AI prototypes using tools like OpenAI, Azure OpenAI, LangChain, or similar frameworks
Help evaluate model performance, safety, and alignment with regulatory and ethical standards
Document findings, create presentations, and contribute to internal knowledge sharing
Participate in brainstorming sessions, demos, and workshops with internal stakeholders

Qualification

PythonMachine LearningGenerative AIData ScienceAnalytical SkillsProblem-SolvingCommunication Skills

Required

Currently enrolled in an accredited graduate program with coursework or a strong background in the fields of Computer Science, Information Systems Data Science, AI/ML, or a related field
Familiarity with Python and machine learning libraries (e.g., PyTorch, TensorFlow, scikit-learn)
Understanding of foundational concepts in generative AI (e.g., transformers, LLMs, prompt engineering)
Strong analytical, problem-solving, and communication skills

Company

Daiichi Sankyo US

company-logo
Daiichi Sankyo US is a pharmaceutical company delivering innovative research, solutions, and treatments to improve health.

H1B Sponsorship

Daiichi Sankyo US has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (32)
2024 (25)
2023 (19)
2022 (12)
2021 (7)
2020 (6)

Funding

Current Stage
Late Stage

Leadership Team

leader-logo
Ken Keller
Chairman of the Board, President and CEO and Head of the Global Oncology Business Unit
linkedin
leader-logo
Christopher Geloso
Senior Region Business Director - ADC Oncology at Daiichi Sankyo, Inc.
linkedin
Company data provided by crunchbase